Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D004088:Dihydroergotoxine / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D008729:Methoxamine / Q000378:metabolism; D009215:Myometrium / Q000378:metabolism*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010643:Phenoxybenzamine / Q000378:metabolism; D010646:Phentolamine / Q000378:metabolism; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000378:metabolism*
D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D008729:Methoxamine; D009638:Norepinephrine; D010646:Phentolamine